Ana Mantrana

Association of Tumor Budding With Immune Evasion Pathways in Primary Colorectal Cancer and Patient-Derived Xenografts

E. Aranda, A. Rodríguez-Ariza, J. R. De la Haba-Rodríguez, 2020, Frontiers in Medicine.

Metabolic shift underlies tumor progression and immune evasion in S‐nitrosoglutathione reductase‐deficient cancer

J. M. Villalba, E. Aranda, A. Rodríguez-Ariza, 2023, The Journal of pathology.

Nitric oxide-targeted therapy inhibits stemness and increases the efficacy of tamoxifen in estrogen receptor-positive breast cancer cells

E. Aranda, A. Rodríguez-Ariza, J. R. De la Haba-Rodríguez, 2020, Laboratory Investigation.

Clinical significance of glycogen synthase kinase 3 (GSK-3) expression and tumor budding grade in colorectal cancer: Implications for targeted therapy.

A. Rodríguez-Ariza, J. R. De la Haba-Rodríguez, C. Villar, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.